Search Results

There are 83572 results for: content related to: The Gift of Drug Samples

  1. Prime time bioethics

    Hastings Center Report

    Volume 42, Issue 2, March-April 2012, Page: 1, Mary Crowley

    Version of Record online : 28 MAR 2012, DOI: 10.1002/hast.19

  2. You have free access to this content
    A Physician Survey of the Effect of Drug Sample Availability on Physicians' Behavior

    Journal of General Internal Medicine

    Volume 15, Issue 7, July 2000, Pages: 478–483, Lisa D. Chew, Theresa S. O'Young, Thomas K. Hazlet, Katharine A. Bradley, Charles Maynard and Daniel S. Lessler

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1525-1497.2000.08014.x

  3. Hastings Center Report Volume 42, 2012

    Hastings Center Report

    Volume 42, Issue 6, November-December 2012, Pages: 48–51,

    Version of Record online : 8 NOV 2012, DOI: 10.1002/hast.112

  4. A Cannabis sativa STR Genotype Database for Australian Seizures: Forensic Applications and Limitations

    Journal of Forensic Sciences

    Volume 54, Issue 3, May 2009, Pages: 556–563, Christopher Howard, Simon Gilmore, James Robertson and Rod Peakall

    Version of Record online : 16 MAR 2009, DOI: 10.1111/j.1556-4029.2009.01014.x

  5. Prescription drug samples – does this marketing strategy counteract policies for quality use of medicines?

    Journal of Clinical Pharmacy and Therapeutics

    Volume 28, Issue 4, August 2003, Pages: 259–271, K. E. M. Groves, I. Sketris and S. E. Tett

    Version of Record online : 11 AUG 2003, DOI: 10.1046/j.1365-2710.2003.00481.x

  6. Trust and Transparency: Patient Perceptions of Physicians' Financial Relationships with Pharmaceutical Companies

    The Journal of Law, Medicine & Ethics

    Volume 42, Issue 4, Winter 2014, Pages: 475–491, Joshua E. Perry, Dena Cox and Anthony D. Cox

    Version of Record online : 6 JAN 2015, DOI: 10.1111/jlme.12169

  7. The Drug Information and Monitoring System (DIMS) in the Netherlands: Implementation, results, and international comparison

    Drug Testing and Analysis

    Volume 3, Issue 9, September 2011, Pages: 621–634, Tibor M. Brunt and Raymond J.M. Niesink

    Version of Record online : 6 SEP 2011, DOI: 10.1002/dta.323

  8. Chemiluminescence detection of MDMA in street drug samples using tris(2,2′-bipyridine)ruthenium(III)

    Drug Testing and Analysis

    Volume 7, Issue 5, May 2015, Pages: 428–432, Ashton G. Theakstone, Zoe M. Smith, Jessica M. Terry, Neil W. Barnett and Paul S. Francis

    Version of Record online : 9 MAR 2015, DOI: 10.1002/dta.1780

  9. Purity, adulteration and price of drugs bought on-line versus off-line in the Netherlands


    Volume 112, Issue 4, April 2017, Pages: 640–648, Daan van der Gouwe, Tibor M. Brunt, Margriet van Laar and Peggy van der Pol

    Version of Record online : 2 FEB 2017, DOI: 10.1111/add.13720

  10. Effect of sampling probe size on dissolution of tableted drug samples

    Journal of Pharmaceutical Sciences

    Volume 70, Issue 2, February 1981, Pages: 232–233, Clyde E. Wells

    Version of Record online : 22 SEP 2006, DOI: 10.1002/jps.2600700234

  11. You have free access to this content
    Samples: to use or not to use?

    Journal of Clinical Pharmacy and Therapeutics

    Volume 30, Issue 6, December 2005, Pages: 505–510, K. K. Daugherty

    Version of Record online : 30 NOV 2005, DOI: 10.1111/j.1365-2710.2005.00691.x

  12. Patient awareness and concern regarding pharmaceutical manufacturer interactions with doctors

    Internal Medicine Journal

    Volume 39, Issue 3, March 2009, Pages: 191–196, D. Edwards and A. Ballantyne

    Version of Record online : 8 APR 2009, DOI: 10.1111/j.1445-5994.2008.01887.x

  13. Rapid screening of 35 new psychoactive substances by ion mobility spectrometry (IMS) and direct analysis in real time (DART) coupled to quadrupole time-of-flight mass spectrometry (QTOF-MS)

    Drug Testing and Analysis

    Volume 7, Issue 10, October 2015, Pages: 884–893, Seongshin Gwak and Jose R. Almirall

    Version of Record online : 18 MAR 2015, DOI: 10.1002/dta.1783

  14. Implicit Cognition and Gifts: How Does social Psychology help Us Think Differently about Medical Practice?

    Hastings Center Report

    Volume 46, Issue 3, May/June 2016, Pages: 33–43, Nicolae Morar and Natalia Washington

    Version of Record online : 6 MAY 2016, DOI: 10.1002/hast.588

  15. The Influences of Pharmaceutical Marketing on APRN Prescribing

    The Advanced Practice Registered Nurse as a Prescriber

    Marie Annette Brown, Louise Kaplan, Pages: 145–174, 2013

    Published Online : 15 MAY 2013, DOI: 10.1002/9781118696965.ch6

  16. Exposure misclassification as a result of free sample drug utilization in automated claims databases and its effect on a pharmacoepidemiology study of selective COX-2 inhibitors

    Pharmacoepidemiology and Drug Safety

    Volume 13, Issue 10, October 2004, Pages: 695–702, Susanna Jacobus, Sebastian Schneeweiss and K. Arnold Chan

    Version of Record online : 29 JUL 2004, DOI: 10.1002/pds.981

  17. The Blame Game: How to Evade the Cost Problem

    Hastings Center Report

    Volume 38, Issue 4, July-August 2008, Page: 49, DANIEL CALLAHAN

    Version of Record online : 8 FEB 2012, DOI: 10.1353/hcr.0.0045

  18. Clinical Use of Placebos: Still the Physician's Prerogative?

    Hastings Center Report

    Volume 42, Issue 3, May-June 2012, Pages: 29–37, Anne Barnhill

    Version of Record online : 23 APR 2012, DOI: 10.1002/hast.33

  19. Analysis of drug contamination from parabens in theophylline olamine

    Journal of Pharmaceutical Sciences

    Volume 70, Issue 6, June 1981, Pages: 589–593, E. C. Juenge, D. F. Gurka and M. A. Kreienbaum

    Version of Record online : 22 SEP 2006, DOI: 10.1002/jps.2600700603

  20. The “Hinxton Group” Considers Transnational Stem Cell Research

    Hastings Center Report

    Volume 36, Issue 3, May-June 2006, Page: 49, JULIAN SAVULESCU and RHODRI SAUNDERS

    Version of Record online : 8 FEB 2012, DOI: 10.1353/hcr.2006.0049